netbook
desktop
mobile
tablet-landscape
tablet
phone-landscape
phone
Research to Prevent Blindness

About RPB

Preserving Vision, Restoring Sight 

Dr. McGinnis looking at information on a computer monitorResearch to Prevent Blindness (RPB) is the leading voluntary health organization supporting eye research directed at the prevention, treatment or eradication of all diseases that threaten vision.

In pursuit of this objective, RPB has committed hundreds of millions of dollars in grant support to provide scientific manpower, technological equipment and eye research laboratory facilities. As a result, RPB researchers have been associated with nearly every major breakthrough in the understanding and treatment of the loss of vision across the past 50 years.

Today, RPB provides major eye research funding to more than 50 leading scientific institutions in the U.S. and supports the work of hundreds of talented vision scientists engaged in a diverse range of disease-oriented research.

RPB's far-reaching activities are planned and carried out with the expert advice and guidance of a Scientific Advisory Panel composed of distinguished leaders in the field of medical science.

RPB neither seeks nor accepts funds from any governmental source. It does not conduct expensive mass mailing campaigns but, rather, relies on bequests and selective appeals to interested individuals, corporations and private foundations to support its research effort.

Anyone wishing information concerning current research findings related to a specific eye disease may contact RPB. To obtain a full description of RPB's programs, its audited financial statements and a listing of the volunteers who serve on its Board of Trustees and Scientific Advisory Committees, download RPB's Annual Report.

Subscribe

Get our email updates filled with the latest news from our researchers about preventing vision loss, treating eye disease and even restoring sight. Unsubscribe at any time. Under our privacy policy, we'll never share your contact information with a third party.